Wednesday, 29 October 2014

Health campaigners to lobby NHS Trust today over pharmacy sell-Off

Photo updated 29.10.14 at 15:30.
No Health Sell Off Campaigners lobby the UHMB Trust Board Meeeting

No Health Sell-off campaigners will lobby today's (Wednesday 29  October) meeting of the University Hospitals of Morecambe Bay NHS Foundation Trust (UHMBT), calling for transparency over the planned sell-off of the trust’s pharmacy services.

The Trust Board will meet from 10am - 12pm in the Lecture Theatre in the Royal Lancaster Infirmary Education Centre. Those wishing to lobby the Trust Board for more transparency about the bidding process and proposed sell-off of hospital pharmacy services in the area will meet there at 9.15am.

Local campaigner Jean withers said:

“We have repeatedly requested to meet with the trust who are making the decision to sell-off the pharmacy. Despite telling the press they will meet us, they are yet to honour that promise. They must not ignore the 9,000 people who signed a petition and are demanding their pharmacy services are not sold-off to private profiteers. Today we’re making it clear to the board that we’re not going anywhere!”

In the evening the group will be holding a public meeting at the Old Hall Pub in Heysham for all residents who are concerned about keeping NHS Trust services intact to meet and discuss the next steps of the campaign.

You can find out more about the No Health Selloff at Morecambe Bay campaign group on their facebook site at https://www.facebook.com/nohealthselloffmorecambebay, where you can also see their gallery of hundreds of photos of supporters from throughout the area signing their petition - giving the lie to MP David Morris' denial that the campaign was 'real'.

You can also contact them tel: 07718668526 / 07718668528 or email nohealthselloffatmorecambebay@gmail.com.

Dates of forthcoming UHMBT board meetings, plus agenda papers, and minutes of previous  meetings, can be found on the Trust’s website:
http://www.uhmb.nhs.uk/about-us/trust-board-meetings/.




No comments: